Dry Needling in Subjects With Delayed Onset Muscle Soreness (TDNDOMS)

July 26, 2023 updated by: Joseph Kelly, Bradley University

Biomechanical Response to Dry Needling in Subjects With Delayed Onset Muscle Soreness: a Double Blind Randomized Control Trial

Investigation of the biomechanical response in delayed onset muscle soreness using dry needling vs. sham

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Illinois
      • Peoria, Illinois, United States, 61625
        • Bradley University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • The participants of the study will be any healthy male or female between
  • age of 18 to 35
  • able and willing to perform an exercise protocol using the gastrocnemius muscle
  • willing to receive either sham or dry needling intervention

Exclusion Criteria:

  • current muscular pain
  • prior trigger point therapy in the past 6 months
  • medications that affect muscle function
  • injury in the past 6 months
  • any health condition that prevents exercising
  • recent surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dry needling
Dry needling intervention to the gastrocnemius muscle trigger point
The use of a solid filiform needle to treat trigger points
Sham Comparator: Sham needling
Sham dry needling intervention to the gastrocnemius muscle trigger point
Simulated needling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Biomechanical stiffness (N/m) using MyotonPRO
Time Frame: baseline, immediately after intervention, 24 hours after intervention
Measuring Biomechanical stiffness ( N/m) change at the following time frames
baseline, immediately after intervention, 24 hours after intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pressure pain threshold using pressure algometry
Time Frame: baseline, immediately after intervention, 24 hours after intervention
Measuring Pressure pain threshold change at the following time frames
baseline, immediately after intervention, 24 hours after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2019

Primary Completion (Actual)

May 23, 2023

Study Completion (Actual)

May 23, 2023

Study Registration Dates

First Submitted

February 5, 2019

First Submitted That Met QC Criteria

March 13, 2019

First Posted (Actual)

March 15, 2019

Study Record Updates

Last Update Posted (Actual)

July 27, 2023

Last Update Submitted That Met QC Criteria

July 26, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Delayed Onset Muscle Soreness

Clinical Trials on Dry needling

3
Subscribe